Add to ORKGIntroduction: Recent studies have demonstrated that inactivated seasonal influenza vaccines (IIV) may elicit production of heterosubtypic antibodies, which can neutralize avian H5N1 virus in a small proportion of subjects. We hypothesized that prime boost regimens of live and inactivated trivalent seasonal influenza vaccines (LAIV and IIV) would enhance production of heterosubtypic immunity and provide evidence of cross-protection against other influenza viruses. Methods: In an open-label study, 26 adult volunteers were randomized to receive one of four vaccine regimens containin
Over last years, a novel strategy for vaccination of people against potentially pandemic influenza A...
BACKGROUND: Cellula r immune responses play a critical role in providing help for the production of ...
It is increasingly clear that influenza A infection induces cross-subtype neutralizing antibodies th...
Recent studies have demonstrated that inactivated seasonal influenza vaccines (IIV) may elicit produ...
Recent studies have demonstrated that inactivated seasonal influenza vaccines (IIV) may elicit produ...
Avian influenza virus (H5N1) can be transmitted to humans, resulting in a severe or fatal disease. T...
Background. Highly pathogenic avian influenza A(H5N1) causes severe infections in humans. We generat...
Avian influenza A (H1N1) in humans is characterized by severe clinical manifestation and high mortal...
Avian influenza A (H1N1) in humans is characterized by severe clinical manifestation and high mortal...
In this thesis, we explore whether the protective efficacy of a trivalent virosomal seasonal influen...
During the past decade, a number of H5 subtype influenza vaccines have been developed and tested in ...
(See the editorial commentary by Falsey on pages 1857–9.) Background. Highly pathogenic avian influe...
Background: It is increasingly clear that influenza A infection induces cross-subtype neutralizing a...
BACKGROUND:It is increasingly clear that influenza A infection induces cross-subtype neutralizing an...
Influenza viruses remain a major threat to global health due to their ability to undergo change thro...
Over last years, a novel strategy for vaccination of people against potentially pandemic influenza A...
BACKGROUND: Cellula r immune responses play a critical role in providing help for the production of ...
It is increasingly clear that influenza A infection induces cross-subtype neutralizing antibodies th...
Recent studies have demonstrated that inactivated seasonal influenza vaccines (IIV) may elicit produ...
Recent studies have demonstrated that inactivated seasonal influenza vaccines (IIV) may elicit produ...
Avian influenza virus (H5N1) can be transmitted to humans, resulting in a severe or fatal disease. T...
Background. Highly pathogenic avian influenza A(H5N1) causes severe infections in humans. We generat...
Avian influenza A (H1N1) in humans is characterized by severe clinical manifestation and high mortal...
Avian influenza A (H1N1) in humans is characterized by severe clinical manifestation and high mortal...
In this thesis, we explore whether the protective efficacy of a trivalent virosomal seasonal influen...
During the past decade, a number of H5 subtype influenza vaccines have been developed and tested in ...
(See the editorial commentary by Falsey on pages 1857–9.) Background. Highly pathogenic avian influe...
Background: It is increasingly clear that influenza A infection induces cross-subtype neutralizing a...
BACKGROUND:It is increasingly clear that influenza A infection induces cross-subtype neutralizing an...
Influenza viruses remain a major threat to global health due to their ability to undergo change thro...
Over last years, a novel strategy for vaccination of people against potentially pandemic influenza A...
BACKGROUND: Cellula r immune responses play a critical role in providing help for the production of ...
It is increasingly clear that influenza A infection induces cross-subtype neutralizing antibodies th...